SECA intelligence
How tech is shaping the world of pharma

How Tech is Shaping the World of Pharma?

The integration of technology is profoundly changing the pharmaceutical sector in the fast- changing healthcare landscape. Pharmaceutical companies are customizing medications to patients’ unique genetic profiles through precision medicine, sophisticated genomics, and personalized treatments, changing patient care.

The field of Pharmaceuticals has seen significant changes in recent years, with the emergence of new technologies playing a vital role in shaping its future. A report from Grand View Research found that the global pharmaceutical technology market size is expected to reach $147.5 billion by 2028. This growth can be attributed Technology is acting as a growth engine for the pharmaceutical sector.

Here is a look at some of the technologies that are changing the pharmaceutical sector as they continue to support its expansion.

  • (AI) Artificial Intelligence: The global artificial intelligence healthcare market is predicted to reach $31.3 billion by 2025, according to a Grand View Research analysis. AI is helping the pharmaceutical business to hasten the process of medication development and production. More businesses are turning to AI to streamline and automate the production process and create efficient post-launch marketing plans. Pharmaceutical businesses are now using AI and Machine Learning (ML) to analyze consumer profiles and assess the effectiveness of various the increasing adoption of digital technologies and platforms in drug discovery and development.
  • Data Analytics and Big Data: One of the main obstacles to the introduction of new treatments or medicines is the expense of R&D. Due to this, the manufacturing and distribution of medicines are frequently insufficient.
  • But employing big data and analytics, pharmaceutical industry researchers can shorten exploration cycles, speeding up the discovery and development of novel treatments. Additionally, pharmaceutical companies can use Big Data to predict a drug’s side effects, reducing the length of time needed for clinical studies.
  • Single-Use Processes: An increasing number of pharmaceutical companies are adopting this technology as part of their manufacturing process. With SUT-powered bioreactors, pharmaceutical companies can develop reliable products without the need to sterilise containers. With less maintenance, companies already utilising SUT to report quick turnaround and manufacturing times as well as simplified operations. Equipment that runs on SUT is quite easy to set up. It takes 1 or 2 hours as compared to stainless setups that can take at least a couple of days. Additionally, maintaining the system is straightforward, without any need for annual cleaning, sterilization validations and minimum monitoring.
  • Bioprinting: One of the major challenges that remain for the pharmaceutical industry is clinical testing. Pharmaceutical companies test the safety and efficacy of a drug on live subjects but thanks to bioprinting, the scenario is about to change. Using techniques similar to 3D-printing, bioprinting can create imitations of human organs and tissues. This technology conjugates cells along with growth factors and various biomaterials to create a mesh-like structure. These organs can replace live subjects in clinical trials. The best part about this technology is that it forms tissues and micro-organs that react in the same manner as does a human body to new drugs and medicines.
  • Blockchain: A single version of the truth may be shared by all parties involved in the manufacturing and supply chain process thanks to blockchain technology. This can guarantee data visibility throughout the whole supply chain. By giving all parties a precise, real-time perspective of the supply chain, blockchain can also break down boundaries between pharmaceutical stakeholders. This is a crucial element to guarantee the manufacturing and supply chain’s robustness.


The landscape of pharmaceutical manufacturing is undergoing a profound transformation due to the integration of technology. Automation and robotics are revolutionizing production processes by ensuring precision and efficiency, while data analytics provide real-time insights for informed decision-making and predictive maintenance, reducing downtime. Continuous manufacturing is enabling seamless, consistent production, and 3D printing is reshaping personalized medicine with customized dosage forms and intricate drug structures. Quality control and serialization are enhanced through advanced imaging and traceability technology. The rise of smart factories and the Industrial Internet of Things (IIoT) is facilitating remote monitoring and control, fostering efficiency and prompt issue resolution. This technological revolution is not only increasing the efficiency of pharmaceutical manufacturing but also paving the way for safer, more personalized, and higher quality drug production that meets the evolving needs of healthcare.

The relentless advancement of technology is profoundly reshaping the pharmaceutical realm, molding an entirely new landscape for healthcare. From precision medicine and AI-powered drug discovery to virtual clinical trials and telemedicine integration, every facet of the pharmaceutical industry is undergoing a metamorphosis. These technological strides promise not only more effective treatments but also a patient-focused approach that revolutionizes healthcare accessibility and delivery. As the synergistic relationship between technology and pharma continues to evolve, we stand on the brink of a transformative era where innovation holds the key to unlocking healthier lives and a better future for all.